<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Miltefosine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Miltefosine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Miltefosine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Miltefosine</b>, sold under the trade name <b>Impavido</b> among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as <i>Naegleria fowleri</i> and <i>Balamuthia mandrillaris</i>.<span class="mw-ref" id="cite_ref-AHFS2016_1-1"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal.<span class="mw-ref" id="cite_ref-FDA2014_3-0"><a href="#cite_note-FDA2014-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It may be used with liposomal amphotericin B or paromomycin.<span class="mw-ref" id="cite_ref-WHO2010_4-0"><a href="#cite_note-WHO2010-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-FDA2014_3-1"><a href="#cite_note-FDA2014-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Miltefosine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Miltefosine_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Miltefosine_structure.svg.png" data-file-width="512" data-file-height="172" data-file-type="drawing" height="84" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Impavido, Miltex, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/miltefosine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/miltefosine.html'" tppabs="https://www.drugs.com/monograph/miltefosine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Miltefosine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Miltefosine'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Miltefosine" class="external text external">Miltefosine</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span><span class="mw-ref" id="cite_ref-AHFS2016_1-0"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>P01CX04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=P01CX04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=P01CX04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=P01CX04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>High</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>~98%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Slow hepatic (non-CYP-dependent)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>6 to 8 days and 31 days<span class="mw-ref" id="cite_ref-dorlo_2-0"><a href="#cite_note-dorlo-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Primarily fecal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">2-(hexadecoxy-oxido-phosphoryl)oxyethyl-trimethyl-azanium</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=58066-85-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=58066-85-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=58066-85-6" class="external text external">58066-85-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3599'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3599" class="external text external">3599</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB09031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB09031'" tppabs="https://www.drugbank.ca/drugs/DB09031" class="external text external">DB09031</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.3473.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.3473.html'" tppabs="http://www.chemspider.com/Chemical-Structure.3473.html" class="external text external">3473</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=53EY29W7EC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=53EY29W7EC'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=53EY29W7EC" class="external text external">53EY29W7EC</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D02494  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D02494'" tppabs="https://www.kegg.jp/entry/D02494" class="external text external">D02494</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75283  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75283'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75283" class="external text external">CHEBI:75283</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL125'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL125" class="external text external">ChEMBL125</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=130571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=130571'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=130571" class="external text external">130571</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7045942  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7045942'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7045942" class="external text external">DTXSID7045942</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.151.328  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.151.328'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.151.328" class="external text external">100.151.328</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>21</sub><span>H</span><sub>46</sub><span>N</span><span>O</span><sub>4</sub><span>P</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">407.576</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BO-%5DP%28%3DO%29%28OCCCCCCCCCCCCCCCC%29OCC%5BN%2B%5D%28C%29%28C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BO-%5DP%28%3DO%29%28OCCCCCCCCCCCCCCCC%29OCC%5BN%2B%5D%28C%29%28C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BO-%5DP%28%3DO%29%28OCCCCCCCCCCCCCCCC%29OCC%5BN%2B%5D%28C%29%28C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>232 to 234<span>&nbsp;</span>°C (450 to 453<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">[O-]P(=O)(OCCCCCCCCCCCCCCCC)OCC[N+](C)(C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:PQLXHQMOHUQAKB-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462252576&page2=Miltefosine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462252576&page2=Miltefosine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462252576&page2=Miltefosine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include vomiting, abdominal pain, fever, headaches, and decreased kidney function.<span class="mw-ref" id="cite_ref-AHFS2016_1-2"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> More severe side effects may include Stevens–Johnson syndrome or low blood platelets.<span class="mw-ref" id="cite_ref-AHFS2016_1-3"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Use during pregnancy appears to cause harm to the baby and use during breastfeeding is not recommended.<span class="mw-ref" id="cite_ref-AHFS2016_1-4"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> How it works is not entirely clear.<span class="mw-ref" id="cite_ref-AHFS2016_1-5"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Miltefosine was first made in the early 1980s and studied as a treatment for cancer.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A few years later it was found to be useful for leishmaniasis and was approved for this use in 2002 in India.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_7-0"><a href="#cite_note-WHO21st-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In the developing world a course of treatment costs US$65 to $150.<span class="mw-ref" id="cite_ref-WHO2010_4-1"><a href="#cite_note-WHO2010-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In the developed world treatment may be 10 to 50 times greater.<span class="mw-ref" id="cite_ref-WHO2010_4-2"><a href="#cite_note-WHO2010-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Leishmaniasis">Leishmaniasis</h3></summary>
    
<p>Miltefosine is primarily used for the treatment of visceral and New World cutaneous leishmaniasis, and is undergoing clinical trials for this use in several countries.<span class="mw-ref" id="cite_ref-FAPEPI_8-0"><a href="#cite_note-FAPEPI-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Soto_9-0"><a href="#cite_note-Soto-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> This drug is now listed as a core medication for the treatment of leishmaniasis under the WHO Model List of Essential Medicines.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however, a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Amoeba_infections">Amoeba infections</h3></summary>
    
<p>Miltefosine has been used successfully in some cases of the very rare, but highly lethal, brain infection by the amoeba, <i>Naegleria fowleri</i>, acquired through water entering the nose during a plunge in contaminated water.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It has orphan drug status in the United States for acanthamoeba keratitis and primary amebic meningoencephalitis (PAM).<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pregnancy_and_breastfeeding">Pregnancy and breastfeeding</h3></summary>
    
<p>Miltefosine is listed as pregnancy category D by the FDA. This means there is evidence-based adverse reaction data from investigational or marketing experience or studies in humans of harm to the human fetus.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span>  Despite this evidence, the potential benefits of miltefosine may warrant use of the drug in pregnant women despite potential risks.  A pregnancy test should be done prior to starting treatment. Effective birth control should be used while on miltefosine and 5 months after discontinuation of treatment. Its use during breast feeding is most likely unsafe.<span class="mw-ref" id="cite_ref-dorlo_2-1"><a href="#cite_note-dorlo-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Miltefosine is contraindicated in individuals who have a hypersensitivity to this medication, pregnant women, and people who have the Sjögren-Larsson syndrome.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> It is embryotoxic and fetotoxic in rats and rabbits, and teratogenic in rats but not in rabbits. It is therefore contraindicated for use during pregnancy, and contraception is required beyond the end of treatment in women of child-bearing age.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Common side effects from miltefosine treatment are nausea and vomiting, which occur in 60% of people. Other common side effects are dizziness, headache, and daytime sleepiness.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Serious side effects include rash, diarrhea, and arthritis.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The side effects are more severe in women and young children. The overall effects are quite mild and easily reversed.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Miltefosine primarily acts on <i>Leishmania</i> by affecting the species's promastigote and amastigote stages.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Miltefosine exerts its activity by interacting with lipids, inhibiting cytochrome c oxidase and causing apoptosis-like cell death.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> This may affect membrane integrity and mitochondrial function of the parasite.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cancer">Cancer</h3></summary>
    
<p>While initially studied as a cancer medication, due to side effects it was never used for this purpose.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>Phospholipid group alkylphosphocholine were known since the early 1980s, particularly in terms of their binding affinity with cobra venom.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> In 1987 the phospholipids were found to be potent toxins on leukemic cell culture.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Initial <i>in vivo</i> investigation on the antineoplastic activity showed positive result, but then only at high dosage and at high toxicity.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> At the same time in Germany, Hansjörg Eibl, at the Max Planck Institute for Biophysical Chemistry, and Clemens Unger, at the University of Göttingen, demonstrated that the antineoplastic activity of the phospholipid analogue miltefosine (at the time known as hexadecylphosphocholine) was indeed tumour-specific. It was highly effective against <a href="N-Nitroso-N-methylurea.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylnitrosourea" title="Methylnitrosourea" class="mw-redirect">methylnitrosourea</a>-induced mammary carcinoma, but less so on transplantable mammary carcinomas and autochthonous benzo(a)pyrene-induced sarcomas, and relatively inactive on Walker 256 carcinosarcoma and autochthonous acetoxymethylmethylnitrosamine-induced colonic tumors of rats.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> It was subsequently found that miltefosine was structurally unique among lipids having anticancer property in that it lacks the <a href="Glycerol.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycerol" title="Glycerol">glycerol</a> group, is highly selective on cell types and acts through different mechanism.<span class="mw-ref" id="cite_ref-Eibl_1990_233–42_29-0"><a href="#cite_note-Eibl_1990_233–42-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Leishmaniasis_2">Leishmaniasis</h3></summary>
    
<p>In the same year as the discovery of the anticancer property, miltefosine was reported by S. L. Croft and his team at the London School of Hygiene and Tropical Medicine as having antileishmanial effect as well. The compound was effective against <i>Leishmania donovani</i> amastigotes in cultured mouse peritoneal macrophages at a dose of 12.8<span>&nbsp;</span>mg/kg/day in a five-day course.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> However, priority was given to the development of the compound for cutaneous metastases of breast cancer. In 1992 a new research was reported in which the compound was highly effective in mouse against different life cycle stages of different <i>Leishmania</i> species, and in fact, more potent than the conventional <a href="Sodium_stibogluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_stibogluconate" title="Sodium stibogluconate">sodium stibogluconate</a> therapy by a factor of more than 600.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Results of the first clinical trial in humans were reported from Indian patients with chronic leishmaniasis with high degree of success and safety.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> This promising development promulgated a unique public–private partnership collaboration between ASTA Medica (later Zentaris GmbH), the World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases, and the Government of India. Eventually, several successful Phase II and III trials led to the approval of miltefosine in 2002 as the first and only oral drug for leishmaniasis.<span class="mw-ref" id="cite_ref-dorlo_2-2"><a href="#cite_note-dorlo-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Naegleria_fowleri_and_Acanthamoeba"><i>Naegleria fowleri</i> and <i>Acanthamoeba</i></h3></summary>
    

<p>In 2013, the US Centers for Disease Control and Prevention recommended miltefosine for the treatment of free-living amoeba infections such as granulomatous amoebic encephalitis and primary amoebic meningoencephalitis, two fatal protozoal diseases.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Historically, only four survivors have been recorded out of 138 confirmed infections in North America. One American survived the infection in 1978 and one individual from Mexico in 2003. In 2013, two children survived and recovered from primary amoebic meningoencephalitis after treatment with miltefosine.<span class="mw-ref" id="cite_ref-cdc_35-0"><a href="#cite_note-cdc-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> In 2016 after treatment that included miltefosine, another child became the fourth person in the United States to survive <i>Naegleria fowleri</i> infection.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    
<p>Miltefosine is commercially available in the United States through Profounda.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Previously one could only get it from the CDC for emergency use under an expanded access IND protocol for treatment of free-living amoeba (FLA) infections: primary amoebic meningoencephalitis caused by <i>Naegleria fowleri</i> and granulomatous amoebic encephalitis caused by <i>Balamuthia mandrillaris</i> and <i>Acanthamoeba</i> species.<span class="mw-ref" id="cite_ref-cdc_35-1"><a href="#cite_note-cdc-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> Miltefosine is also produced by Profounda, a private pharmaceutical company.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_research">Further research</h2></summary>
    
<p>It is active against some bacteria and fungi,<span class="mw-ref" id="cite_ref-dorlo_2-3"><a href="#cite_note-dorlo-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> as well as human trematode <i>Schistosoma mansoni</i> and the snail that spreads it <i>Biomphalaria alexandrina</i>.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Antiprotozoal_and_antifungal_activities">Antiprotozoal and antifungal activities</h3></summary>
    
<p>Miltefosine is being investigated by researchers interested in finding treatments for infections which have become resistant to existing drugs.  Animal and <i>in vitro</i> studies suggest it may have broad anti-protozoal and anti-fungal properties:</p>
<ul><li>Animal studies suggest miltefosine may also be effective against <i>Trypanosoma cruzi</i>, the parasite responsible for Chagas' disease.<span class="mw-ref" id="cite_ref-Saraiva_42-0"><a href="#cite_note-Saraiva-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></li>
<li>Several studies have found the drug to be effective against types of fungus: <i>Cryptococcus neoformans</i>, <i>Candida</i>, <i>Aspergillus</i> and <i>Fusarium</i>.<span class="mw-ref" id="cite_ref-Widmer_43-0"><a href="#cite_note-Widmer-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></li>
<li>A 2006 <i>in vitro</i> study found that miltefosine is effective against metronidazole-resistant variants of <i>Trichomonas vaginalis</i>, a sexually transmitted protozoal disease.<span class="mw-ref" id="cite_ref-pmid16344287_44-0"><a href="#cite_note-pmid16344287-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></li>
<li>Cetrimonium bromide, a compound related to miltefosine, was demonstrated in 2007 to exhibit potent <i>in vitro</i> activity against <i>Plasmodium falciparum</i>.<span class="mw-ref" id="cite_ref-Choubey2006_45-0"><a href="#cite_note-Choubey2006-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></li>
<li>An <i>in vitro</i> test in 2006 showed that miltefosine is effective against the deadly protozoan pathogens, <i>Naegleria fowleri</i>, <i>Balamuthia mandrillaris</i>, and <i>Acanthamoeba</i>.<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> However, later studies showed that it is not as potent as other drugs, such as <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a><span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> and diminazene aceturate (Berenil).<span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></li>
<li>In 2013, there were reports of failure of miltefosine in the treatment of leishmaniasis.<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> Although drug resistance was suspected, studies in 2014 reported that miltefosine is not so effective in children, most probably related to a lack of drug exposure in children.<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Moverover, males appeared to have a higher probability of relapse as well.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></li>
<li>A 2012 <i>in vitro</i> study found that miltefosine had promising activity against <i>Candida albicans</i> biofilms.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Anti-HIV_activity">Anti-HIV activity</h3></summary>
    

<p>Miltefosine targets HIV infected macrophages, which play a role in vivo as long-lived HIV-1 reservoirs. The HIV protein Tat activates pro-survival PI3K/Akt pathway in primary human macrophages.  Miltefosine acts by inhibiting the PI3K/Akt pathway, thus removing the infected macrophages from circulation, without affecting healthy cells.<span class="mw-ref" id="cite_ref-pmid18237430_54-0"><a href="#cite_note-pmid18237430-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-titleAIDSmeds.com_-_Top_Stories_:_Parasitic_Drug_Shows_HIV-Fighting_Promise_55-0"><a href="#cite_note-titleAIDSmeds.com_-_Top_Stories_:_Parasitic_Drug_Shows_HIV-Fighting_Promise-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> It significantly reduces replication of HIV-1 in cocultures of human dendritic cells (DCs) and CD4<sup>+</sup> T cells, which is due to a rapid secretion of soluble factors and is associated with induction of type-I interferon (IFN) in the human cells.<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2016-1"> <span id="mw-reference-text-cite_note-AHFS2016-1" class="mw-reference-text"><cite id="CITEREFAmerican_Society_of_Health-System_Pharmacists2016" class="citation web cs1">American Society of Health-System Pharmacists (26 February 2016). <a href="javascript:if(confirm('https://www.drugs.com/monograph/miltefosine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/miltefosine.html'" tppabs="https://www.drugs.com/monograph/miltefosine.html" class="external text external">"Miltefosine Monograph for Professionals"</a>. <i>www.drugs.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161117145201/https://www.drugs.com/monograph/miltefosine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161117145201/https://www.drugs.com/monograph/miltefosine.html'" tppabs="https://web.archive.org/web/20161117145201/https://www.drugs.com/monograph/miltefosine.html" class="external text external">Archived</a> from the original on 17 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">16 November</span> 2016</span>.</cite></span></li><li id="cite_note-dorlo-2"> <span id="mw-reference-text-cite_note-dorlo-2" class="mw-reference-text"><cite id="CITEREFDorloBalasegaram,_M.Beijnen,_J._H.de_Vries,_P._J.2012" class="citation journal cs1">Dorlo, T. P. C.; Balasegaram, M.; Beijnen, J. H.; de Vries, P. J. (2012). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dks275  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dks275'" tppabs="https://doi.org/10.1093/jac/dks275" class="external text external">"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>67</b> (11): 2576–2597. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdks275  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdks275'" tppabs="https://doi.org/10.1093%2Fjac%2Fdks275" class="external text external">10.1093/jac/dks275</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22833634  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22833634'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22833634" class="external text external">22833634</a>.</cite></span></li><li id="cite_note-FDA2014-3"> <span id="mw-reference-text-cite_note-FDA2014-3" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm'" tppabs="https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm" class="external text external">"FDA approves Impavido to treat tropical disease leishmaniasis"</a>. <i>U.S. Food and Drug Administration (FDA)</i> (Press release). 19 March 2014. <a href="javascript:if(confirm('https://web.archive.org/web/20140903082843/https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140903082843/https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm'" tppabs="https://web.archive.org/web/20140903082843/https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm389671.htm" class="external text external">Archived</a> from the original on 3 September 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2014</span>.</cite></span></li><li id="cite_note-WHO2010-4"> <span id="mw-reference-text-cite_note-WHO2010-4" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2010" class="citation book cs1">World Health Organization (March 2010). <i>Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases</i>. World Health Organization. pp.<span>&nbsp;</span>59, 88, 186. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10665%2F44412  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F44412'" tppabs="https://hdl.handle.net/10665%2F44412" class="external text external">10665/44412</a>. ISBN<span>&nbsp;</span><bdi>9789241209496</bdi>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFGreenwood2008" class="citation book cs1">Greenwood, David (2008). <a href="javascript:if(confirm('https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310'" tppabs="https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310" class="external text external"><i>Antimicrobial Drugs: Chronicle of a Twentieth Century Medical Triumph</i></a>. OUP Oxford. p.<span>&nbsp;</span>310. ISBN<span>&nbsp;</span><bdi>9780199534845</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910151716/https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910151716/https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310'" tppabs="https://web.archive.org/web/20170910151716/https://books.google.com/books?id=i4_FZHmzjzwC&pg=PA310" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFKumar2013" class="citation book cs1">Kumar, Awanish (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39'" tppabs="https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39" class="external text external"><i>Leishmania and Leishmaniasis</i></a>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>39. ISBN<span>&nbsp;</span><bdi>9781461488699</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910151716/https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910151716/https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39'" tppabs="https://web.archive.org/web/20170910151716/https://books.google.com/books?id=5eG5BAAAQBAJ&pg=PA39" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-WHO21st-7"> <span id="mw-reference-text-cite_note-WHO21st-7" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-FAPEPI-8"> <span id="mw-reference-text-cite_note-FAPEPI-8" class="mw-reference-text"><cite id="CITEREFCristinaPedrosa,_Robert2005" class="citation news cs1">Cristina, Márcia; Pedrosa, Robert (September 2005). <a href="javascript:if(confirm('https://web.archive.org/web/20060822060527/http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060822060527/http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php'" tppabs="https://web.archive.org/web/20060822060527/http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php" class="external text external">"Hospital de Doenças Tropicais testa droga contra calazar"</a>. <i>Sapiência</i> (in Portuguese). Fundação de Amparo à Pesquisa do Estado do Piauí. Archived from <a href="javascript:if(confirm('http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php'" tppabs="http://www.fapepi.pi.gov.br/sapiencia6/pesquisa3.php" class="external text external">the original</a> on 2006-08-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-09-01</span></span>.</cite></span></li><li id="cite_note-Soto-9"> <span id="mw-reference-text-cite_note-Soto-9" class="mw-reference-text"><cite id="CITEREFSotoBerman2006" class="citation journal cs1">Soto J, Berman J (2006). <a href="javascript:if(confirm('https://zenodo.org/record/1259409  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1259409'" tppabs="https://zenodo.org/record/1259409" class="external text external">"Treatment of New World cutaneous leishmaniasis with miltefosine"</a>. <i>Trans R Soc Trop Med Hyg</i>. <b>100</b>: S34–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.trstmh.2006.02.022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.trstmh.2006.02.022'" tppabs="https://doi.org/10.1016%2Fj.trstmh.2006.02.022" class="external text external">10.1016/j.trstmh.2006.02.022</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16930649  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16930649'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16930649" class="external text external">16930649</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFWHO2015" class="citation web cs1">WHO (2015). <a href="javascript:if(confirm('http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf'" tppabs="http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf" class="external text external">"19th WHO Model List of Essential Medicines"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf'" tppabs="https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 13 May 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">8 November</span> 2016</span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFBerman2005" class="citation journal cs1">Berman, J. (2005). "Clinical status of agents being developed for leishmaniasis". <i>Expert Opinion on Investigational Drugs</i>. <b>14</b> (11): 1337–1346. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F13543784.14.11.1337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F13543784.14.11.1337'" tppabs="https://doi.org/10.1517%2F13543784.14.11.1337" class="external text external">10.1517/13543784.14.11.1337</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16255674  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16255674'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16255674" class="external text external">16255674</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFLinamAhmedCopeChu2015" class="citation journal cs1">Linam, W. Matthew; Ahmed, Mubbasheer; Cope, Jennifer R.; Chu, Craig; Visvesvara, Govinda S.; Silva, Alexandre J. da; Qvarnstrom, Yvonne; Green, Jerril (2015-03-01). <a href="javascript:if(confirm('http://pediatrics.aappublications.org/content/135/3/e744  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pediatrics.aappublications.org/content/135/3/e744'" tppabs="http://pediatrics.aappublications.org/content/135/3/e744" class="external text external">"Successful Treatment of an Adolescent With Naegleria fowleri Primary Amebic Meningoencephalitis"</a>. <i>Pediatrics</i>. <b>135</b> (3): e744–e748. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.2014-2292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.2014-2292'" tppabs="https://doi.org/10.1542%2Fpeds.2014-2292" class="external text external">10.1542/peds.2014-2292</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0031-4005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0031-4005'" tppabs="https://www.worldcat.org/issn/0031-4005" class="external text external">0031-4005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634363  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634363'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634363" class="external text external">4634363</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25667249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25667249'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25667249" class="external text external">25667249</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20160409070020/http://pediatrics.aappublications.org/content/135/3/e744  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160409070020/http://pediatrics.aappublications.org/content/135/3/e744'" tppabs="https://web.archive.org/web/20160409070020/http://pediatrics.aappublications.org/content/135/3/e744" class="external text external">Archived</a> from the original on 2016-04-09.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFInc." class="citation web cs1">Inc., Profounda. <a href="javascript:if(confirm('http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html'" tppabs="http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html" class="external text external">"Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencephalitis (PAM) with Miltefosine"</a>. <i>www.prnewswire.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161222072200/http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161222072200/http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html'" tppabs="https://web.archive.org/web/20161222072200/http://www.prnewswire.com/news-releases/profounda-inc-receives-fda-orphan-drug-designation-for-the-treatment-of-primary-amebic-meningoencephalitis-pam-with-miltefosine-300379937.html" class="external text external">Archived</a> from the original on 2016-12-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-05-25</span></span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1">Inc., Profounda. <a href="javascript:if(confirm('http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html'" tppabs="http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html" class="external text external">"FDA Orphan Drug Designation Granted to Profounda Inc. for the treatment of Acanthamoeba Keratitis with miltefosine"</a>. <i>www.prnewswire.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161221002837/http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161221002837/http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html'" tppabs="https://web.archive.org/web/20161221002837/http://www.prnewswire.com/news-releases/fda-orphan-drug-designation-granted-to-profounda-inc-for-the-treatment-of-acanthamoeba-keratitis-with-miltefosine-300380273.html" class="external text external">Archived</a> from the original on 2016-12-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-05-25</span></span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy-categories.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy-categories.html'" tppabs="https://www.drugs.com/pregnancy-categories.html" class="external text external">"New FDA Pregnancy Categories Explained - Drugs.com"</a>. <i>www.drugs.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161116163852/https://www.drugs.com/pregnancy-categories.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161116163852/https://www.drugs.com/pregnancy-categories.html'" tppabs="https://web.archive.org/web/20161116163852/https://www.drugs.com/pregnancy-categories.html" class="external text external">Archived</a> from the original on 2016-11-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-16</span></span>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e" class="external text external">"Impavido- miltefosine capsule"</a>. <i>DailyMed</i>. Profounda, Inc. 5 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">26 December</span> 2019</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFSindermannEngel,_J.2006" class="citation journal cs1">Sindermann, H.; Engel, J. (2006). "Development of miltefosine as an oral treatment for leishmaniasis". <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>. <b>100</b> (Suppl 1): S17–S20. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.trstmh.2006.02.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.trstmh.2006.02.010'" tppabs="https://doi.org/10.1016%2Fj.trstmh.2006.02.010" class="external text external">10.1016/j.trstmh.2006.02.010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16730362  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16730362'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16730362" class="external text external">16730362</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/sfx/miltefosine-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/sfx/miltefosine-side-effects.html'" tppabs="https://www.drugs.com/sfx/miltefosine-side-effects.html" class="external text external">"Miltefosine Side Effects in Detail - Drugs.com"</a>. <i>www.drugs.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html'" tppabs="https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html" class="external text external">Archived</a> from the original on 2016-11-17<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-16</span></span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/sfx/miltefosine-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/sfx/miltefosine-side-effects.html'" tppabs="https://www.drugs.com/sfx/miltefosine-side-effects.html" class="external text external">"Drugs.com - Miltefosine Side Effects"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html'" tppabs="https://web.archive.org/web/20161117070506/https://www.drugs.com/sfx/miltefosine-side-effects.html" class="external text external">Archived</a> from the original on 2016-11-17.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFS.D._Seth2008" class="citation book cs1">S.D. Seth (2008). "Drug therapy of leishmaniasis".  In S.D. Seth (ed.). <a href="javascript:if(confirm('https://books.google.com/books?id=51ozlZRBvQwC&pg  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=51ozlZRBvQwC&pg'" tppabs="https://books.google.com/books?id=51ozlZRBvQwC&pg" class="external text external"><i>Textbook of Pharmacology</i></a>. Elsevier India. p.<span>&nbsp;</span>31. ISBN<span>&nbsp;</span><bdi>9788131211588</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910151716/https://books.google.com/books?id=51ozlZRBvQwC&pg  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910151716/https://books.google.com/books?id=51ozlZRBvQwC&pg'" tppabs="https://web.archive.org/web/20170910151716/https://books.google.com/books?id=51ozlZRBvQwC&pg" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine'" tppabs="http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine" class="external text external">"Impavido New FDA Drug Approval | CenterWatch"</a>. <i>www.centerwatch.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161104192249/http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161104192249/http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine'" tppabs="https://web.archive.org/web/20161104192249/http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1311/impavido-miltefosine" class="external text external">Archived</a> from the original on 2016-11-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-09</span></span>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFFDA" class="citation web cs1">FDA. <a href="javascript:if(confirm('https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf'" tppabs="https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf" class="external text external">"Miltefosine (Impravido) for the Treatment of Visceral, Mucosal and Cutaneous Leishmaniasis"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20161024125444/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161024125444/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf'" tppabs="https://web.archive.org/web/20161024125444/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM371074.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2016-10-24<span class="reference-accessdate">. Retrieved <span class="nowrap">9 Nov</span> 2016</span>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFCohenPowderlyOpal2016" class="citation book cs1">Cohen, Jonathan; Powderly, William G.; Opal, Steven M. (2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367'" tppabs="https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367" class="external text external"><i>Infectious Diseases</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>1367. ISBN<span>&nbsp;</span><bdi>9780702063381</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910151716/https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910151716/https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367'" tppabs="https://web.archive.org/web/20170910151716/https://books.google.com/books?id=Dhq3DAAAQBAJ&pg=PA1367" class="external text external">Archived</a> from the original on 2017-09-10.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFTeshimaIkeda,_KHamaguchi,_KHayashi,_K1983" class="citation journal cs1">Teshima, K; Ikeda, K; Hamaguchi, K; Hayashi, K (1983). "Bindings of cobra venom phospholipases A2 to micelles of n-hexadecylphosphorylcholine". <i>Journal of Biochemistry</i>. <b>94</b> (1): 223–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Foxfordjournals.jbchem.a134333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Foxfordjournals.jbchem.a134333'" tppabs="https://doi.org/10.1093%2Foxfordjournals.jbchem.a134333" class="external text external">10.1093/oxfordjournals.jbchem.a134333</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6619110  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6619110'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6619110" class="external text external">6619110</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFFleerUnger,_CKim,_DJEibl,_H1987" class="citation journal cs1">Fleer, EA; Unger, C; Kim, DJ; Eibl, H (1987). "Metabolism of ether phospholipids and analogs in neoplastic cells". <i>Lipids</i>. <b>22</b> (11): 856–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02535544  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02535544'" tppabs="https://doi.org/10.1007%2Fbf02535544" class="external text external">10.1007/bf02535544</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3444378  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3444378'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3444378" class="external text external">3444378</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFBergerPetru,_ESchmähl,_D1987" class="citation journal cs1">Berger, MR; Petru, E; Schmähl, D (1987). "Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea-induced rat mammary carcinoma". <i>Journal of Cancer Research and Clinical Oncology</i>. <b>113</b> (5): 437–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf00390037  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf00390037'" tppabs="https://doi.org/10.1007%2Fbf00390037" class="external text external">10.1007/bf00390037</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3624299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3624299'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3624299" class="external text external">3624299</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFMuschiolBerger,_MRSchuler,_BScherf,_HR1987" class="citation journal cs1">Muschiol, C; Berger, MR; Schuler, B; Scherf, HR; Garzon, FT; Zeller, WJ; Unger, C; Eibl, HJ; Schmähl, D (1987). "Alkyl phosphocholines: toxicity and anticancer properties". <i>Lipids</i>. <b>22</b> (11): 930–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fbf02535558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fbf02535558'" tppabs="https://doi.org/10.1007%2Fbf02535558" class="external text external">10.1007/bf02535558</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3444388  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3444388'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3444388" class="external text external">3444388</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFBergerMuschiol,_CSchmähl,_DEibl,_HJ1987" class="citation journal cs1">Berger, MR; Muschiol, C; Schmähl, D; Eibl, HJ (1987). "New cytostatics with experimentally different toxic profiles". <i>Cancer Treatment Reviews</i>. <b>14</b> (3–4): 307–17. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0305-7372%2887%2990023-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0305-7372%2887%2990023-5'" tppabs="https://doi.org/10.1016%2F0305-7372%2887%2990023-5" class="external text external">10.1016/0305-7372(87)90023-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3440252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3440252'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3440252" class="external text external">3440252</a>.</cite></span></li><li id="cite_note-Eibl_1990_233–42-29"> <span id="mw-reference-text-cite_note-Eibl_1990_233–42-29" class="mw-reference-text"><cite id="CITEREFEiblUnger,_C1990" class="citation journal cs1">Eibl, H; Unger, C (1990). "Hexadecylphosphocholine: a new and selective antitumor drug". <i>Cancer Treatment Reviews</i>. <b>17</b> (2–3): 233–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0305-7372%2890%2990053-i  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0305-7372%2890%2990053-i'" tppabs="https://doi.org/10.1016%2F0305-7372%2890%2990053-i" class="external text external">10.1016/0305-7372(90)90053-i</a>. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/11858%2F00-001M-0000-0013-0D40-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/11858%2F00-001M-0000-0013-0D40-8'" tppabs="https://hdl.handle.net/11858%2F00-001M-0000-0013-0D40-8" class="external text external">11858/00-001M-0000-0013-0D40-8</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2272038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2272038'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2272038" class="external text external">2272038</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFHilgardStekar,_JVoegeli,_REngel,_J1988" class="citation journal cs1">Hilgard, P; Stekar, J; Voegeli, R; Engel, J; Schumacher, W; Eibl, H; Unger, C; Berger, MR (1988). "Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)". <i>European Journal of Cancer &amp; Clinical Oncology</i>. <b>24</b> (9): 1457–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0277-5379%2888%2990336-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0277-5379%2888%2990336-7'" tppabs="https://doi.org/10.1016%2F0277-5379%2888%2990336-7" class="external text external">10.1016/0277-5379(88)90336-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3141197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3141197'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3141197" class="external text external">3141197</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFCroftNeal,_R.A.Pendergast,_W.Chan,_J.H.1987" class="citation journal cs1">Croft, S.L.; Neal, R.A.; Pendergast, W.; Chan, J.H. (1987). "The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani". <i>Biochemical Pharmacology</i>. <b>36</b> (16): 2633–2636. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0006-2952%2887%2990543-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0006-2952%2887%2990543-0'" tppabs="https://doi.org/10.1016%2F0006-2952%2887%2990543-0" class="external text external">10.1016/0006-2952(87)90543-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3606662  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3606662'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3606662" class="external text external">3606662</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFKuhlencordManiera,_TEibl,_HUnger,_C1992" class="citation journal cs1">Kuhlencord, A; Maniera, T; Eibl, H; Unger, C (1992). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021" class="external text external">"Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>36</b> (8): 1630–1634. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.36.8.1630  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.36.8.1630'" tppabs="https://doi.org/10.1128%2FAAC.36.8.1630" class="external text external">10.1128/AAC.36.8.1630</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC192021" class="external text external">192021</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1329624  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1329624'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1329624" class="external text external">1329624</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFSundarRosenkaimer,_FrankMakharia,_Manoj_KGoyal,_Ashish_K1998" class="citation journal cs1">Sundar, Shyam; Rosenkaimer, Frank; Makharia, Manoj K; Goyal, Ashish K; Mandal, Ashim K; Voss, Andreas; Hilgard, Peter; Murray, Henry W (1998). "Trial of oral miltefosine for visceral leishmaniasis". <i>The Lancet</i>. <b>352</b> (9143): 1821–1823. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2898%2904367-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2898%2904367-0'" tppabs="https://doi.org/10.1016%2FS0140-6736%2898%2904367-0" class="external text external">10.1016/S0140-6736(98)04367-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9851383  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9851383'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9851383" class="external text external">9851383</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFCope2013" class="citation journal cs1">Cope, Jennifer R (2013). <a href="javascript:if(confirm('https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm'" tppabs="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm" class="external text external">"Investigational drug available directly from CDC for the treatment of infections with free-living amebae"</a>. <i>MMWR. Morbidity and Mortality Weekly Report</i>. <b>62</b> (33): 666. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604798  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604798'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604798" class="external text external">4604798</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23965830  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23965830'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23965830" class="external text external">23965830</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170711092614/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170711092614/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm'" tppabs="https://web.archive.org/web/20170711092614/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6233a4.htm" class="external text external">Archived</a> from the original on 2017-07-11.</cite></span></li><li id="cite_note-cdc-35"> <span id="mw-reference-text-cite_note-cdc-35" class="mw-reference-text"><cite id="CITEREFCDC2014" class="citation web cs1">CDC (2014). <a href="javascript:if(confirm('https://www.cdc.gov/parasites/naegleria/treatment.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/parasites/naegleria/treatment.html'" tppabs="https://www.cdc.gov/parasites/naegleria/treatment.html" class="external text external">"Naegleria fowleri - Primary Amebic Meningoencephalitis (PAM)"</a>. Centers for Disease Control and Prevention. <a href="javascript:if(confirm('https://web.archive.org/web/20150214042623/http://www.cdc.gov/parasites/naegleria/treatment.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150214042623/http://www.cdc.gov/parasites/naegleria/treatment.html'" tppabs="https://web.archive.org/web/20150214042623/http://www.cdc.gov/parasites/naegleria/treatment.html" class="external text external">Archived</a> from the original on 14 February 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2014</span>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFGholipour2013" class="citation web cs1">Gholipour, Bahar (14 August 2013). <a href="javascript:if(confirm('http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html'" tppabs="http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html" class="external text external">"Brain-Eating Amoeba: How One Girl Survived"</a>. <i>livescience</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20141003131011/http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141003131011/http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html'" tppabs="https://web.archive.org/web/20141003131011/http://www.livescience.com/38897-how-to-survive-a-brain-eating-amoeba.html" class="external text external">Archived</a> from the original on 3 October 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">29 August</span> 2014</span>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFGoldschmidtScutti" class="citation news cs1">Goldschmidt, Debra; Scutti, Susan. <a href="javascript:if(confirm('http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/'" tppabs="http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/" class="external text external">"Rare recovery: Florida teen survives brain-eating amoeba"</a>. CNN. <a href="javascript:if(confirm('https://web.archive.org/web/20160824145826/http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160824145826/http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/'" tppabs="https://web.archive.org/web/20160824145826/http://www.cnn.com/2016/08/23/health/brain-eating-amoeba-florida-teen-survives/" class="external text external">Archived</a> from the original on 24 August 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">23 August</span> 2016</span>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite class="citation web cs1">Inc., Profounda. <a href="javascript:if(confirm('http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html'" tppabs="http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html" class="external text external">"Profounda, Inc. launches Impavido (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous leishmaniasis, in the United States"</a>. <i>www.prnewswire.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170316075853/http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170316075853/http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html'" tppabs="https://web.archive.org/web/20170316075853/http://www.prnewswire.com/news-releases/profounda-inc-launches-impavido-miltefosine-the-first-and-only-oral-rx-treatment-for-visceral-mucosal-and-cutaneous-leishmaniasis-in-the-united-states-300238867.html" class="external text external">Archived</a> from the original on 2017-03-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-05-25</span></span>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp'" tppabs="http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp" class="external text external">"A life-saving drug that treats a rare infection is almost impossible to find"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20160919150218/http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160919150218/http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp'" tppabs="https://web.archive.org/web/20160919150218/http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp" class="external text external">Archived</a> from the original on 2016-09-19<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-01</span></span>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFAlmeida_PachioniMagalhães,_JGCardoso_Lima,_EJMoura_Bueno,_LD2013" class="citation journal cs1">Almeida Pachioni, JD; Magalhães, JG; Cardoso Lima, EJ; Moura Bueno, LD; Barbosa, JF; Malta de Sá, M; Rangel-Yagui, CO (2013). <a href="javascript:if(confirm('https://doi.org/10.18433/J3CW23  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18433/J3CW23'" tppabs="https://doi.org/10.18433/J3CW23" class="external text external">"Alkylphospholipids - a promising class of chemotherapeutic agents with a broad pharmacological spectrum"</a>. <i>Journal of Pharmacy &amp; Pharmaceutical Sciences</i>. <b>16</b> (5): 742–59. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.18433%2FJ3CW23  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18433%2FJ3CW23'" tppabs="https://doi.org/10.18433%2FJ3CW23" class="external text external">10.18433/J3CW23</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24393556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24393556'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24393556" class="external text external">24393556</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFEissaEl_Bardicy,_SamiaTadros,_Menerva2011" class="citation journal cs1">Eissa, Maha M; El Bardicy, Samia; Tadros, Menerva (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006" class="external text external">"Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy"</a>. <i>Parasites &amp; Vectors</i>. <b>4</b> (1): 73. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1756-3305-4-73  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1756-3305-4-73'" tppabs="https://doi.org/10.1186%2F1756-3305-4-73" class="external text external">10.1186/1756-3305-4-73</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114006" class="external text external">3114006</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21569375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21569375'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21569375" class="external text external">21569375</a>.</cite></span></li><li id="cite_note-Saraiva-42"> <span id="mw-reference-text-cite_note-Saraiva-42" class="mw-reference-text"><cite id="CITEREFSaraivaGibaldiPreviatoMendonça-Previato2002" class="citation journal cs1">Saraiva V, Gibaldi D, Previato J, Mendonça-Previato L, Bozza M, Freire-De-Lima C, Heise N (2002). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733" class="external text external">"Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi"</a>. <i>Antimicrob Agents Chemother</i>. <b>46</b> (11): 3472–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.46.11.3472-3477.2002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.46.11.3472-3477.2002'" tppabs="https://doi.org/10.1128%2FAAC.46.11.3472-3477.2002" class="external text external">10.1128/AAC.46.11.3472-3477.2002</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128733" class="external text external">128733</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12384352  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12384352'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12384352" class="external text external">12384352</a>.</cite></span></li><li id="cite_note-Widmer-43"> <span id="mw-reference-text-cite_note-Widmer-43" class="mw-reference-text"><cite id="CITEREFWidmerWrightObandoHandke2006" class="citation journal cs1">Widmer F, Wright L, Obando D, Handke R, Ganendren R, Ellis D, Sorrell T (2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877" class="external text external">"Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis"</a>. <i>Antimicrob Agents Chemother</i>. <b>50</b> (2): 414–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.50.2.414-421.2006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.50.2.414-421.2006'" tppabs="https://doi.org/10.1128%2FAAC.50.2.414-421.2006" class="external text external">10.1128/AAC.50.2.414-421.2006</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1366877" class="external text external">1366877</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16436691  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16436691'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16436691" class="external text external">16436691</a>.</cite></span></li><li id="cite_note-pmid16344287-44"> <span id="mw-reference-text-cite_note-pmid16344287-44" class="mw-reference-text"><cite id="CITEREFBlahaDuchêneAspöckWalochnik2006" class="citation journal cs1">Blaha C, Duchêne M, Aspöck H, Walochnik J (2006). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dki417  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dki417'" tppabs="https://doi.org/10.1093/jac/dki417" class="external text external">"In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis"</a>. <i>J. Antimicrob. Chemother</i>. <b>57</b> (2): 273–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdki417  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdki417'" tppabs="https://doi.org/10.1093%2Fjac%2Fdki417" class="external text external">10.1093/jac/dki417</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16344287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16344287'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16344287" class="external text external">16344287</a>.</cite></span></li><li id="cite_note-Choubey2006-45"> <span id="mw-reference-text-cite_note-Choubey2006-45" class="mw-reference-text"><cite id="CITEREFChoubeyMaityGuha2007" class="citation journal cs1">Choubey V, Maity P, Guha M,  et al. (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733" class="external text external">"Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism"</a>. <i>Antimicrob. Agents Chemother</i>. <b>51</b> (2): 696–706. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.00919-06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.00919-06'" tppabs="https://doi.org/10.1128%2FAAC.00919-06" class="external text external">10.1128/AAC.00919-06</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797733" class="external text external">1797733</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17145794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17145794'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17145794" class="external text external">17145794</a>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFSchusterGuglielmoVisvesvara2006" class="citation journal cs1">Schuster, FL; Guglielmo, BJ; Visvesvara, GS (2006). "In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas:<i> Balamuthia mandrillaris</i>, <i>Acanthamoeba</i> spp., and <i>Naegleria fowleri</i>". <i>The Journal of Eukaryotic Microbiology</i>. <b>53</b> (2): 121–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1550-7408.2005.00082.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1550-7408.2005.00082.x'" tppabs="https://doi.org/10.1111%2Fj.1550-7408.2005.00082.x" class="external text external">10.1111/j.1550-7408.2005.00082.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16579814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16579814'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16579814" class="external text external">16579814</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFKimJungLeeSong2008" class="citation journal cs1">Kim, J.-H.; Jung, S.-Y.; Lee, Y.-J.; Song, K.-J.; Kwon, D.; Kim, K.; Park, S.; Im, K.-I.; Shin, H.-J. (2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150" class="external text external">"Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to <i>Naegleria fowleri</i>"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>52</b> (11): 4010–4016. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.00197-08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.00197-08'" tppabs="https://doi.org/10.1128%2FAAC.00197-08" class="external text external">10.1128/AAC.00197-08</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573150" class="external text external">2573150</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18765686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18765686'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18765686" class="external text external">18765686</a>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFAhmadHeaselgraveAndrewKilvington2013" class="citation journal cs1">Ahmad, Arine F.; Heaselgrave, Wayne; Andrew, Peter W.; Kilvington, Simon (2013). "The in vitro efficacy of antimicrobial agents against the pathogenic free-living amoeba <i>Balamuthia mandrillaris</i>". <i>Journal of Eukaryotic Microbiology</i>. <b>60</b> (5): 539–543. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fjeu.12062  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fjeu.12062'" tppabs="https://doi.org/10.1111%2Fjeu.12062" class="external text external">10.1111/jeu.12062</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23869955  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23869955'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23869955" class="external text external">23869955</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFRijalOstynUranwRai2013" class="citation journal cs1">Rijal, S.; Ostyn, B.; Uranw, S.; Rai, K.; Bhattarai, N. R.; Dorlo, T. P. C.; Beijnen, J. H.; Vanaerschot, M.; Decuypere, S.; Dhakal, S. S.; Das, M. L.; Karki, P.; Singh, R.; Boelaert, M.; Dujardin, J.-C. (2013). <a href="javascript:if(confirm('https://doi.org/10.1093/cid/cit102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/cid/cit102'" tppabs="https://doi.org/10.1093/cid/cit102" class="external text external">"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance"</a>. <i>Clinical Infectious Diseases</i>. <b>56</b> (11): 1530–1538. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fcid%2Fcit102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fcid%2Fcit102'" tppabs="https://doi.org/10.1093%2Fcid%2Fcit102" class="external text external">10.1093/cid/cit102</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23425958  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23425958'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23425958" class="external text external">23425958</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFRaiCuypersBhattaraiUranw2013" class="citation journal cs1">Rai, K.; Cuypers, B.; Bhattarai, N. R.; Uranw, S.; Berg, M.; Ostyn, B.; Dujardin, J.-C.; Rijal, S.; Vanaerschot, M. (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894" class="external text external">"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting <i>Leishmania donovani</i> strain"</a>. <i>mBio</i>. <b>4</b> (5): e00611–13–e00611–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FmBio.00611-13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FmBio.00611-13'" tppabs="https://doi.org/10.1128%2FmBio.00611-13" class="external text external">10.1128/mBio.00611-13</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791894" class="external text external">3791894</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24105765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24105765'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24105765" class="external text external">24105765</a>.</cite></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite id="CITEREFDorloRijalOstynde_Vries2014" class="citation journal cs1">Dorlo, T. P. C.; Rijal, S.; Ostyn, B.; de Vries, P. J.; Singh, R.; Bhattarai, N.; Uranw, S.; Dujardin, J.-C.; Boelaert, M.; Beijnen, J. H.; Huitema, A. D. R. (2014). <a href="javascript:if(confirm('https://doi.org/10.1093/infdis/jiu039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/infdis/jiu039'" tppabs="https://doi.org/10.1093/infdis/jiu039" class="external text external">"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure"</a>. <i>Journal of Infectious Diseases</i>. <b>210</b> (1): 146–153. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Finfdis%2Fjiu039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Finfdis%2Fjiu039'" tppabs="https://doi.org/10.1093%2Finfdis%2Fjiu039" class="external text external">10.1093/infdis/jiu039</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24443541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24443541'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24443541" class="external text external">24443541</a>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFOstynHaskerDorloRijal2014" class="citation journal cs1">Ostyn, Bart; Hasker, Epco; Dorlo, Thomas P. C.; Rijal, Suman; Sundar, Shyam; Dujardin, Jean-Claude; Boelaert, Marleen; Ng, Lisa FP. (2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493" class="external text external">"Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia"</a>. <i>PLoS ONE</i>. <b>9</b> (6): e100220. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2014PLoSO...9j0220O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2014PLoSO...9j0220O'" tppabs="https://ui.adsabs.harvard.edu/abs/2014PLoSO...9j0220O" class="external text external">2014PLoSO...9j0220O</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0100220  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0100220'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0100220" class="external text external">10.1371/journal.pone.0100220</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062493" class="external text external">4062493</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24941345  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24941345'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24941345" class="external text external">24941345</a>.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite id="CITEREFVilaIshidaSouzaProusis2013" class="citation journal cs1">Vila, Taissa V. M.; Ishida, Kelly; Souza, Wanderley de; Prousis, Kyriakos; Calogeropoulou, Theodora; Rozental, Sonia (2013-01-01). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dks353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dks353'" tppabs="https://doi.org/10.1093/jac/dks353" class="external text external">"Effect of alkylphospholipids on Candida albicans biofilm formation and maturation"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>68</b> (1): 113–125. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdks353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdks353'" tppabs="https://doi.org/10.1093%2Fjac%2Fdks353" class="external text external">10.1093/jac/dks353</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0305-7453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0305-7453'" tppabs="https://www.worldcat.org/issn/0305-7453" class="external text external">0305-7453</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22995097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22995097'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22995097" class="external text external">22995097</a>.</cite></span></li><li id="cite_note-pmid18237430-54"> <span id="mw-reference-text-cite_note-pmid18237430-54" class="mw-reference-text"><cite id="CITEREFChughBradel-TrethewayMonteiro-Filho2008" class="citation journal cs1">Chugh P, Bradel-Tretheway B, Monteiro-Filho CM,  et al. (2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748" class="external text external">"Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy"</a>. <i>Retrovirology</i>. <b>5</b> (1): 11. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1742-4690-5-11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1742-4690-5-11'" tppabs="https://doi.org/10.1186%2F1742-4690-5-11" class="external text external">10.1186/1742-4690-5-11</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265748" class="external text external">2265748</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18237430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18237430'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18237430" class="external text external">18237430</a>.</cite></span></li><li id="cite_note-titleAIDSmeds.com_-_Top_Stories_:_Parasitic_Drug_Shows_HIV-Fighting_Promise-55"> <span id="mw-reference-text-cite_note-titleAIDSmeds.com_-_Top_Stories_:_Parasitic_Drug_Shows_HIV-Fighting_Promise-55" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml'" tppabs="http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml" class="external text external">"Parasitic Drug Shows HIV-Fighting Promise"</a>. AIDSmeds.com. 2008-02-01. <a href="javascript:if(confirm('https://web.archive.org/web/20080212122209/http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080212122209/http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml'" tppabs="https://web.archive.org/web/20080212122209/http://www.aidsmeds.com/articles/hiv_miltefosine_macrophages_1667_13933.shtml" class="external text external">Archived</a> from the original on 2008-02-12<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</cite></span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite id="CITEREFGargTremblay,_Michel_J.2012" class="citation journal cs1">Garg, Ravendra; Tremblay, Michel J. (2012). <a href="javascript:if(confirm('https://doi.org/10.1016/j.virol.2012.05.032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.virol.2012.05.032'" tppabs="https://doi.org/10.1016/j.virol.2012.05.032" class="external text external">"Miltefosine represses HIV-1 replication in human dendritic cell/T-cell cocultures partially by inducing secretion of type-I interferon"</a>. <i>Virology</i>. <b>432</b> (2): 271–276. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.virol.2012.05.032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.virol.2012.05.032'" tppabs="https://doi.org/10.1016%2Fj.virol.2012.05.032" class="external text external">10.1016/j.virol.2012.05.032</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22704066  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22704066'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22704066" class="external text external">22704066</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/miltefosine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/miltefosine'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/miltefosine" class="external text external">"Miltefosine"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><a href="javascript:if(confirm('http://www.max-planck-innovation.de/de/aktuelles/pressemitteilungen/news.php?Dafra%20Pharma%20R%26D%20has%20been%20awarded%20an%20exclusive%20licence%20from%20the%20Max%20Planck%20Society%20to%20develop%20a%20drug%20against%20leishmaniasis&id=365  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.max-planck-innovation.de/de/aktuelles/pressemitteilungen/news.php?Dafra%20Pharma%20R%26D%20has%20been%20awarded%20an%20exclusive%20licence%20from%20the%20Max%20Planck%20Society%20to%20develop%20a%20drug%20against%20leishmaniasis&id=365'" tppabs="http://www.max-planck-innovation.de/de/aktuelles/pressemitteilungen/news.php?Dafra%20Pharma%20R%26D%20has%20been%20awarded%20an%20exclusive%20licence%20from%20the%20Max%20Planck%20Society%20to%20develop%20a%20drug%20against%20leishmaniasis&id=365" class="external text external">Max Planck Innovation</a></li>
<li><a href="javascript:if(confirm('http://www.medscape.com/viewarticle/812862  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/812862'" tppabs="http://www.medscape.com/viewarticle/812862" class="external text external">FDA Panel Endorses Miltefosine for Leishmaniasis</a></li>
<li><a href="javascript:if(confirm('http://www.medindia.net/doctors/drug_information/miltefosine.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medindia.net/doctors/drug_information/miltefosine.htm'" tppabs="http://www.medindia.net/doctors/drug_information/miltefosine.htm" class="external text external">Med India</a></li>
<li><a href="javascript:if(confirm('https://www.drugs.com/international/miltefosine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/miltefosine.html'" tppabs="https://www.drugs.com/international/miltefosine.html" class="external text external">Drugs.com</a></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="font-size:114%;margin:0 4em">Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Entry/fusion inhibitors <br> <i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>gp41</i> (<a href="Enfuvirtide.htm" tppabs="https://ptable.com/wiki/compounds/A/Enfuvirtide" title="Enfuvirtide">Enfuvirtide (ENF, T-20)</a>)</li>
<li><i>CCR5</i> (<a href="Maraviroc.htm" tppabs="https://ptable.com/wiki/compounds/A/Maraviroc" title="Maraviroc">Maraviroc (MVC)</a></li>
<li>Vicriviroc<sup>†</sup>, Cenicriviroc<sup>†</sup>, PRO 140<sup>†</sup>)</li>
<li><i>CD4</i> (Ibalizumab<sup>†</sup>, UB421<sup>§</sup>)</li>
<li><i>gp120</i> (Fostemsavir)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Reverse-transcriptase<br> inhibitors (RTIs)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleoside and<br> nucleotide (NRTI)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NRTIs:</i>  <a href="Abacavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Abacavir" title="Abacavir">Abacavir (ABC)</a>°<sup>#</sup></li>
<li><a href="Didanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Didanosine" title="Didanosine">Didanosine (ddI)</a></li>
<li><a href="Emtricitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Emtricitabine" title="Emtricitabine">Emtricitabine (FTC)</a>°</li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine (3TC)</a>°<sup>#</sup></li>
<li><a href="Stavudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Stavudine" title="Stavudine">Stavudine (d4T)</a><sup>#</sup></li>
<li><a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">Zidovudine (AZT, ZDV)</a><sup>#</sup></li>
<li>Amdoxovir<sup>†</sup></li>
<li>Apricitabine<sup>†</sup></li>
<li>Censavudine<sup>†</sup></li>
<li>Elvucitabine<sup>†</sup></li>
<li>Islatravir (EFdA)<sup>§</sup></li>
<li>Racivir<sup>†</sup></li>
<li>Stampidine<sup>†</sup></li>
<li><a href="Zalcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zalcitabine" title="Zalcitabine">Zalcitabine (ddC)</a><sup>◊</sup></li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i>  Tenofovir disoproxil (TDF)°<sup>#</sup></li>
<li>Tenofovir alafenamide (TAF)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-nucleoside (NNRTI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz (EFV)</a>°<sup>#</sup></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine (NVP)</a><sup>#</sup></li>
<li><a href="Delavirdine.htm" tppabs="https://ptable.com/wiki/compounds/A/Delavirdine" title="Delavirdine">Delavirdine (DLV)</a><sup>◊</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>diarylpyrimidines</i>
<ul><li>Etravirine (ETR)</li>
<li>Rilpivirine (RPV)°</li></ul></li>
<li>Doravirine°</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Integrase inhibitors<br>(Integrase strand transfer inhibitors (INSTI))</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dolutegravir (DTG)°</li>
<li>Elvitegravir (EVG)°</li>
<li>Raltegravir (RAL)°</li>
<li>BI 224436<sup>†</sup></li>
<li>Cabotegravir<sup>†</sup></li>
<li>Bictegravir (BIC)<sup>†</sup></li>
<li>MK-2048<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Maturation inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bevirimat<sup>†</sup></li>
<li>BMS-955176<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Protease Inhibitors (PI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Amprenavir" title="Amprenavir">Amprenavir (APV)</a><sup>◊</sup></li>
<li><a href="Fosamprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosamprenavir" title="Fosamprenavir">Fosamprenavir (FPV)</a></li>
<li><a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">Indinavir (IDV)</a><sup>◊</sup></li>
<li><a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">Lopinavir (LPV)</a></li>
<li><a href="Nelfinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelfinavir" title="Nelfinavir">Nelfinavir (NFV)</a></li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (RTV)</a><sup>#</sup></li>
<li><a href="Saquinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Saquinavir" title="Saquinavir">Saquinavir (SQV)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atazanavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Atazanavir" title="Atazanavir">Atazanavir (ATV)</a>°<sup>#</sup></li>
<li><a href="Darunavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Darunavir" title="Darunavir">Darunavir (DRV)</a>°<sup>#</sup></li>
<li><a href="Tipranavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Tipranavir" title="Tipranavir">Tipranavir (TPV)</a></li>
<li>TMC-310911<sup>§</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combined formulations</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abacavir/lamivudine°<sup>#</sup></li>
<li>Abacavir/dolutegravir/lamivudine°</li>
<li>Abacavir/lamivudine/zidovudine</li>
<li>Atazanavir/cobicistat</li>
<li>Bictegravir/emtricitabine/tenofovir alafenamide</li>
<li>Darunavir/cobicistat</li>
<li>Darunavir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Dolutegravir/lamivudine</li>
<li>Dolutegravir/lamivudine/tenofovir</li>
<li>Dolutegravir/rilpivirine</li>
<li>Doravirine/lamivudine/tenofovir</li>
<li>Efavirenz/emtricitabine/tenofovir°<sup>#</sup></li>
<li>Efavirenz/lamivudine/tenofovir<sup>#</sup></li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir°</li>
<li>Emtricitabine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir°</li>
<li>Emtricitabine/tenofovir°<sup>#</sup></li>
<li>Lamivudine/nevirapine/stavudine<sup>#</sup></li>
<li>Lamivudine/nevirapine/zidovudine<sup>#</sup></li>
<li>Lamivudine/raltegravir</li>
<li>Lamivudine/tenofovir</li>
<li>Lamivudine/zidovudine<sup>#</sup></li>
<li>Lopinavir/ritonavir°<sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pharmacokinetic boosters</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cobicistat (c)</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (r)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Uncoating inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TRIM5alpha (gene)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Transcription inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tat antagonists</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Translation inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Trichosanthin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"> BNAbs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Elipovimab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abzyme</li>
<li>BIT225<sup>†</sup></li>
<li>Calanolide A</li>
<li>Ceragenin</li>
<li>Cyanovirin-N</li>
<li>Diarylpyrimidines</li>
<li><a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">Epigallocatechin gallate (EGCG)</a></li>
<li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li>
<li>Fosdevirine<sup>†</sup></li>
<li>Griffithsin</li>
<li><a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a></li>
<li>KP-1461<sup>†</sup></li>
<li><a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a></li>
<li>Portmanteau inhibitors</li>
<li>Scytovirin</li>
<li>Seliciclib<sup>†</sup></li>
<li>Synergistic enhancers</li>
<li>Tre recombinase</li>
<li>Zinc finger protein transcription factor</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Failed agents</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aplaviroc</li>
<li>Atevirdine</li>
<li>Brecanavir</li>
<li>Capravirine</li>
<li>Dexelvucitabine</li>
<li>Droxinavir</li>
<li>Lasinavir</li>
<li>Emivirine</li>
<li>Lersivirine</li>
<li>Lodenosine</li>
<li>Loviride</li>
<li>Mozenavir</li>
<li><span class="new">Palinavir</span></li>
<li><span class="new">Telinavir</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div> °DHHS <i>recommended</i> initial regimen options. <sup>◊</sup>Formerly or rarely used agent.<br></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antiparasitics_–_antiprotozoal_agents_–_Excavata_antiparasitics_(P01)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiparasitics_–_antiprotozoal_agents_–_Excavata_antiparasitics_(P01)" style="font-size:114%;margin:0 4em">Antiparasitics<span>&nbsp;</span>– antiprotozoal agents<span>&nbsp;</span>– Excavata antiparasitics (P01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Discicristata</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Trypanosomiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">African trypanosomiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine">ornithine</a> (<a href="Eflornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eflornithine" title="Eflornithine">Eflornithine</a><sup>#</sup>)</li>
<li>arsenical (Melarsoprol<sup>#</sup>)</li>
<li><a href="Benzamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamidine" title="Benzamidine">benzamidine</a> (<a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">Pentamidine</a><sup>#</sup>)</li>
<li>naphthalenesulfonate (<a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a><sup>#</sup>)<br></li>
<li>nitroimidazole (Fexinidazole<sup>†</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Chagas disease</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (Benznidazole<sup>#</sup>)</li>
<li>nitrofuran (Nifurtimox<sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Leishmaniasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>macrolide (<a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">Amphotericin B</a><sup>#</sup>)</li></ul>

<p>Pentavalent antimonials (Meglumine antimoniate<sup>#</sup>, <a href="Sodium_stibogluconate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_stibogluconate" title="Sodium stibogluconate">Sodium stibogluconate</a>)</p>

<ul><li><a href="Benzamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzamidine" title="Benzamidine">benzamidine</a> (<a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">Pentamidine</a><sup>#</sup>)</li>
<li>phosphorylcholine (<a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a>)</li>
<li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">neomycin</a> (<a href="Paromomycin_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Paromomycin_sulfate" title="Paromomycin sulfate" class="mw-redirect">Paromomycin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PAM</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>macrolide (<a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">Amphotericin B</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Trichozoa</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Giardiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (<a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a><sup>#</sup>, <a href="Tinidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Tinidazole" title="Tinidazole">Tinidazole</a>)</li>
<li><a href="Benzimidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzimidazole" title="Benzimidazole">benzimidazole</a> (<a href="Albendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Albendazole" title="Albendazole">Albendazole</a>)</li></ul>

<ul><li><span class="new">thiazolide</span> (<a href="Nitazoxanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitazoxanide" title="Nitazoxanide">Nitazoxanide</a>)</li>
<li>nitrofuran (<a href="Furazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazolidone" title="Furazolidone">Furazolidone</a>)</li></ul>

<ul><li><a href="9-Aminoacridine.htm" tppabs="https://ptable.com/wiki/compounds/A/9-Aminoacridine" title="9-Aminoacridine">aminoacridine</a> (<a href="Quinacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinacrine" title="Quinacrine" class="mw-redirect">Quinacrine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Trichomoniasis</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (Carnidazole, <a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a><sup>#</sup>, <a href="Tinidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Tinidazole" title="Tinidazole">Tinidazole</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Dientamoebiasis</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>nitroimidazole (<a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a></li>
<li>Secnidazole)<br></li></ul>

<ul><li><a href="8-Hydroxyquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxyquinoline" title="Oxyquinoline" class="mw-redirect">oxyquinoline</a> (<a href="Diiodohydroxyquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Diiodohydroxyquinoline" title="Diiodohydroxyquinoline">Iodoquinol</a>)</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">tetracycline</a> (<a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a>)</li>
<li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">neomycin </a> (Paromomycin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antifungals_(D01_and_J02)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antifungals_(D01_and_J02)" style="font-size:114%;margin:0 4em">Antifungals (D01 and J02)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Wall/<br>membrane</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Ergosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergosterol" title="Ergosterol">Ergosterol</a><br>inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Azole.htm" tppabs="https://ptable.com/wiki/compounds/A/Azole" title="Azole">Azoles</a> (lanosterol 14α-<br>demethylase inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Imidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Imidazole" title="Imidazole">Imidazoles</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: <a href="Bifonazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Bifonazole" title="Bifonazole">bifonazole</a><sup>‡</sup></li>
<li><a href="Butoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Butoconazole" title="Butoconazole">butoconazole</a></li>
<li>chlormidazole<sup>‡</sup></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">clotrimazole</a><sup>#</sup></li>
<li>croconazole<sup>‡</sup></li>
<li>eberconazole</li>
<li><a href="Econazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Econazole" title="Econazole">econazole</a></li>
<li>fenticonazole<sup>‡</sup></li>
<li>flutrimazole</li>
<li>isoconazole</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a></li>
<li>luliconazole</li>
<li><a href="Miconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Miconazole" title="Miconazole">miconazole</a><sup>#</sup></li>
<li>neticonazole<sup>‡</sup></li>
<li>omoconazole<sup>‡</sup></li>
<li><a href="Oxiconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxiconazole" title="Oxiconazole">oxiconazole</a></li>
<li><a href="Sertaconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertaconazole" title="Sertaconazole">sertaconazole</a></li>
<li>sulconazole</li>
<li><a href="Tioconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Tioconazole" title="Tioconazole">tioconazole</a></li></ul>

<ul><li>Systemic: ketoconazole</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Triazoles</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: efinaconazole</li>
<li><a href="Fluconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluconazole" title="Fluconazole">fluconazole</a><sup>#</sup></li>
<li><a href="Terconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Terconazole" title="Terconazole">terconazole</a></li></ul>

<ul><li>Systemic: fluconazole<sup>#</sup></li>
<li>hexaconazole<sup>‡</sup></li>
<li>fosfluconazole</li>
<li>isavuconazole</li>
<li><a href="Itraconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Itraconazole" title="Itraconazole">itraconazole</a><sup>#</sup></li>
<li><a href="Posaconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Posaconazole" title="Posaconazole">posaconazole</a></li>
<li><a href="Voriconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Voriconazole" title="Voriconazole">voriconazole</a><sup>#</sup></li></ul>

<ul><li>Unknown: albaconazole<sup>‡</sup></li>
<li>ravuconazole<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Thiazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiazole" title="Thiazole">Thiazoles</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: abafungin<sup>‡</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Polyene antimycotics<br>(<a href="Ergosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergosterol" title="Ergosterol">ergosterol</a> binding)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: hamycin<sup>‡</sup></li>
<li><a href="Natamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Natamycin" title="Natamycin">natamycin</a></li>
<li><a href="Nystatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nystatin" title="Nystatin">nystatin</a><sup>#</sup><br>Systemic: <a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">amphotericin B</a><sup>#</sup>, hamycin<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Squalene monooxygenase<br>inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Allylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylamine" title="Allylamine">Allylamines</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: <a href="Naftifine.htm" tppabs="https://ptable.com/wiki/compounds/A/Naftifine" title="Naftifine">naftifine</a></li>
<li><a href="Terbinafine.htm" tppabs="https://ptable.com/wiki/compounds/A/Terbinafine" title="Terbinafine">terbinafine</a><br>Systemic: terbinafine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Benzylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylamine" title="Benzylamine">Benzylamines</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: <a href="Butenafine.htm" tppabs="https://ptable.com/wiki/compounds/A/Butenafine" title="Butenafine">butenafine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: <a href="Amorolfine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amorolfine" title="Amorolfine">amorolfine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">β-glucan synthase<br>inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Systemic: echinocandins (<a href="Anidulafungin.htm" tppabs="https://ptable.com/wiki/compounds/A/Anidulafungin" title="Anidulafungin">anidulafungin</a></li>
<li><span class="new">biafungin</span></li>
<li><a href="Caspofungin.htm" tppabs="https://ptable.com/wiki/compounds/A/Caspofungin" title="Caspofungin">caspofungin</a></li>
<li>cilofungin</li>
<li><a href="Micafungin.htm" tppabs="https://ptable.com/wiki/compounds/A/Micafungin" title="Micafungin">micafungin</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine analogues/<br>thymidylate synthase inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Systemic: <a href="Flucytosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucytosine" title="Flucytosine">flucytosine</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Mitotic inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Systemic: <a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">griseofulvin</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Aminoacyl tRNA synthetase inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Topical: tavaborole</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>bromochlorosalicylanilide</li>
<li><a href="Chlorophetanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorophetanol" title="Chlorophetanol">chlorophetanol</a></li>
<li><a href="Chlorphenesin.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenesin" title="Chlorphenesin" class="mw-redirect">chlorphenesin</a></li>
<li><a href="Ciclopirox.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciclopirox" title="Ciclopirox">ciclopirox</a></li>
<li><a href="Crystal_violet.htm" tppabs="https://ptable.com/wiki/compounds/A/Crystal_violet" title="Crystal violet">crystal violet</a></li>
<li>dimazole</li>
<li><a href="Ethylparaben.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylparaben" title="Ethylparaben">ethylparaben</a></li>
<li><a href="Haloprogin.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloprogin" title="Haloprogin">haloprogin</a><sup>‡</sup></li>
<li>polynoxylin</li>
<li><a href="Potassium_iodide.htm" tppabs="https://ptable.com/wiki/compounds/A/Potassium_iodide" title="Potassium iodide">potassium iodide</a><sup>#</sup></li>
<li><a href="Salicylic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Salicylic_acid" title="Salicylic acid">salicylic acid</a></li>
<li><a href="Selenium_disulfide.htm" tppabs="https://ptable.com/wiki/compounds/A/Selenium_disulfide" title="Selenium disulfide">selenium disulfide</a><sup>#</sup></li>
<li><a href="Sodium_thiosulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_thiosulfate" title="Sodium thiosulfate">sodium thiosulfate</a><sup>#</sup></li>
<li>sulbentine</li>
<li>taurolidine</li>
<li>ticlatone</li>
<li>tolciclate</li>
<li><a href="Tolnaftate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolnaftate" title="Tolnaftate">tolnaftate</a></li>
<li>tribromometacresol</li>
<li><a href="Undecylenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Undecylenic_acid" title="Undecylenic acid">undecylenic acid</a></li>
<li>Whitfield's ointment<sup>#</sup></li></ul>

<ul><li>citronella oil</li>
<li>lemon grass</li>
<li>lemon myrtle</li>
<li>orange oil</li>
<li>patchouli</li>
<li><a href="Tea_tree_oil.htm" tppabs="https://ptable.com/wiki/compounds/A/Tea_tree_oil" title="Tea tree oil">tea tree oil</a></li>
<li>PCP: <a href="Atovaquone.htm" tppabs="https://ptable.com/wiki/compounds/A/Atovaquone" title="Atovaquone">atovaquone</a></li>
<li><a href="Dapsone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dapsone" title="Dapsone">dapsone</a></li>
<li><a href="Pentamidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentamidine" title="Pentamidine">pentamidine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-02" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Miltefosine&oldid=970845462  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Miltefosine&oldid=970845462'" tppabs="https://en.wikipedia.org/wiki/?title=Miltefosine&oldid=970845462">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>